Skip to main content
丹娜生物 logo

丹娜生物 — Investor Relations & Filings

Ticker · 920009 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 61 across all filing types
Latest filing 2025-12-21 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920009

About 丹娜生物

https://www.dynamiker.com/

Dynamiker Biotechnology specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) solutions, focusing on the early detection and monitoring of invasive fungal diseases (IFD). The company offers a comprehensive diagnostic portfolio targeting pathogens such as Aspergillus, Candida, Cryptococcus, and Pneumocystis jirovecii. Its core product lines include (1-3)-β-D-glucan (G test), Galactomannan (GM test), and Cryptococcal Antigen (CrAg) assays, utilizing methodologies like ELISA, lateral flow, and molecular diagnostics. These products are designed to provide rapid, sensitive, and specific results for clinical decision-making. Dynamiker maintains international quality standards and certifications, supporting its commitment to improving diagnostic accuracy and patient management in global healthcare settings.

Recent filings

Filing Released Lang Actions
2025年第五次临时股东会会议决议
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2025 fifth extraordinary shareholders meeting of 丹娜（天津）生物科技股份有限公司. It includes details about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the legality and validity of the meeting and its resolutions. There is no financial data or detailed report content; rather, it is an official announcement of voting results from a shareholders meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1621 characters), and it is clearly a voting results announcement, not a full report or presentation.
2025-12-21 Chinese
公司章程
Governance Information Classification · 95% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 丹娜（天津）生物科技股份有限公司 dated December 2025. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, capital, and governance rules. It references relevant laws and regulatory frameworks such as the Company Law of China, Securities Law, and Beijing Stock Exchange listing rules. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report, announcement, or meeting material. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not a brief announcement or summary. Therefore, the correct classification is CGR with high confidence.
2025-12-21 Chinese
2025年第五次临时股东会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality of a company's 2025 fifth extraordinary shareholders meeting. It details the meeting's convening, attendance, voting procedures, and results, confirming their compliance with relevant laws and company bylaws. It does not contain financial data, earnings, or management discussion, nor is it a report or announcement of financial results. Instead, it is a legal opinion related to the conduct and results of a shareholder meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2735 characters, which is relatively short but contains substantive content about voting results and legal validation, not just an announcement of a report publication. Therefore, the best classification is DVA with high confidence.
2025-12-21 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of using idle raised funds for cash management by the company 丹娜(天津)生物科技股份有限公司. It details the authorization, investment products, risk control measures, and risk warnings related to the use of idle raised funds for cash management. The document includes specific investment amounts, product types, and compliance with disclosure rules. It is not a full financial report, audit report, or earnings release, but rather a regulatory disclosure about capital management activities involving raised funds. This fits the category of Capital/Financing Update (CAP), as it updates on the company's use of raised capital for cash management purposes.
2025-12-15 Chinese
关于拟变更公司注册资本、公司类型及修订〈公司章程〉并办理工商变更登记的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the proposed changes to the company's registered capital, company type, and amendments to the Articles of Association (公司章程). It details the reasons for the amendments, specific changes to the Articles, and mentions that these changes will be submitted for shareholder approval and registration with the industrial and commercial administration. The document does not contain financial statements or detailed financial performance data. It is a formal corporate announcement about governance and structural changes rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company structure and governance-related updates.
2025-12-03 Chinese
重大投资和交易决策制度
Governance Information Classification · 95% confidence The document is a detailed announcement of the company's "重大投资和交易决策制度" (Major Investment and Transaction Decision System) which outlines the decision-making authority, approval thresholds, and procedures for major investments and transactions. It includes references to relevant laws, company bylaws, and regulatory requirements. The document is a formal announcement of a governance policy approved by the board and shareholders, rather than a financial report or earnings release. It does not contain financial statements or audit results, nor is it a transcript or presentation. It is a governance-related document detailing internal rules and procedures for decision-making on major investments and transactions. Therefore, it fits best under Governance Information (CGR). The document length is about 4784 characters, which is substantive and not a mere announcement of a report publication or certification. Hence, the classification is CGR with high confidence.
2025-12-03 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.